Literature DB >> 16537593

Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.

Cara Carthel Burns1, Jing Shaw, Ray Campagnoli, Jaume Jorba, Annelet Vincent, Jacqueline Quay, Olen Kew.   

Abstract

We replaced degenerate codons for nine amino acids within the capsid region of the Sabin type 2 oral poliovirus vaccine strain with corresponding nonpreferred synonymous codons. Codon replacements were introduced into four contiguous intervals spanning 97% of the capsid region. In the capsid region of the most highly modified virus construct, the effective number of codons used (N(C)) fell from 56.2 to 29.8, the number of CG dinucleotides rose from 97 to 302, and the G+C content increased from 48.4% to 56.4%. Replicative fitness in HeLa cells, measured by plaque areas and virus yields in single-step growth experiments, decreased in proportion to the number of replacement codons. Plaque areas decreased over an approximately 10-fold range, and virus yields decreased over an approximately 65-fold range. Perhaps unexpectedly, the synthesis and processing of viral proteins appeared to be largely unaltered by the restriction in codon usage. In contrast, total yields of viral RNA in infected cells were reduced approximately 3-fold and specific infectivities of purified virions (measured by particle/PFU ratios) decreased approximately 18-fold in the most highly modified virus. The replicative fitness of both codon replacement viruses and unmodified viruses increased with the passage number in HeLa cells. After 25 serial passages (approximately 50 replication cycles), most codon replacements were retained, and the relative fitness of the modified viruses remained well below that of the unmodified virus. The increased replicative fitness of high-passage modified virus was associated with the elimination of several CG dinucleotides. Potential applications for the systematic modulation of poliovirus replicative fitness by deoptimization of codon usage are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537593      PMCID: PMC1440415          DOI: 10.1128/JVI.80.7.3259-3272.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  The extent of codon usage bias in human RNA viruses and its evolutionary origin.

Authors:  Gareth M Jenkins; Edward C Holmes
Journal:  Virus Res       Date:  2003-03       Impact factor: 3.303

2.  Evidence that the bypassing ribosome travels through the coding gap.

Authors:  Jonathan Gallant; Paul Bonthuis; Dale Lindsley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-23       Impact factor: 11.205

3.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Gene order of the poliovirus capsid proteins.

Authors:  D Rekosh
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Control of haemoglobin synthesis: rate of translation of the messenger RNA for the alpha and beta chains.

Authors:  T Hunt; T Hunter; A Munro
Journal:  J Mol Biol       Date:  1969-07-14       Impact factor: 5.469

7.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems.

Authors:  Anjali Yadava; Christian F Ockenhouse
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region.

Authors:  Betty Brown; M Steven Oberste; Kaija Maher; Mark A Pallansch
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 10.  Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli.

Authors:  J F Kane
Journal:  Curr Opin Biotechnol       Date:  1995-10       Impact factor: 9.740

View more
  120 in total

1.  Slow fitness recovery in a codon-modified viral genome.

Authors:  J J Bull; I J Molineux; C O Wilke
Journal:  Mol Biol Evol       Date:  2012-04-24       Impact factor: 16.240

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.

Authors:  Steffen Mueller; Dimitris Papamichail; J Robert Coleman; Steven Skiena; Eckard Wimmer
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 4.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

5.  Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.

Authors:  Maria L Yakovenko; Ekaterina A Korotkova; Olga E Ivanova; Tatyana P Eremeeva; Elena Samoilovich; Iryna Uhova; Gene V Gavrilin; Vadim I Agol
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

6.  Global RNA structure analysis of poliovirus identifies a conserved RNA structure involved in viral replication and infectivity.

Authors:  Cecily P Burrill; Oscar Westesson; Michael B Schulte; Vanessa R Strings; Mark Segal; Raul Andino
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Diagnostic Assay Development for Poliovirus Eradication.

Authors:  Nancy Gerloff; Hong Sun; Mark Mandelbaum; Chelsea Maher; W Allan Nix; Sohail Zaidi; Shahzad Shaukat; Lerato Seakamela; Uma P Nalavade; Deepa K Sharma; M Steven Oberste; Everardo Vega
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

8.  Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids.

Authors:  M Isabel Costafreda; Francisco J Pérez-Rodriguez; Lucía D'Andrea; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 9.  New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

Authors:  Konstantin Chumakov; Ellie Ehrenfeld
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

10.  Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.

Authors:  Cara C Burns; Ray Campagnoli; Jing Shaw; Annelet Vincent; Jaume Jorba; Olen Kew
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.